177A — Kohjin Bio Co Balance Sheet
0.000.00%
- ¥9bn
- ¥8bn
- ¥5bn
- 80
- 51
- 19
- 50
Annual balance sheet for Kohjin Bio Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | Yuho |
Standards: | JAS | JAS | JAS |
Status: | Final | Final | Final |
Cash and Equivalents | |||
Cash and Short Term Investments | 1,734 | 1,463 | 1,727 |
Net Total Accounts Receivable | |||
Net Total Receivables | 1,151 | 847 | 927 |
Total Inventory | |||
Total Other Current Assets | |||
Total Current Assets | 3,434 | 3,479 | 3,410 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 1,709 | 2,172 | 2,587 |
Net Intangible Assets | |||
Long Term Investments | |||
Other Long Term Assets | |||
Total Assets | 5,595 | 6,135 | 6,589 |
Accounts Payable | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 2,198 | 3,022 | 2,398 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Deferred Income Tax | |||
Total Other Liabilities | |||
Total Funded Status | |||
Total Liabilities | 3,378 | 3,117 | 3,247 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Unrealized Gain / Loss | |||
Other Equity | |||
Total Equity | 2,217 | 3,018 | 3,342 |
Total Liabilities & Shareholders' Equity | 5,595 | 6,135 | 6,589 |
Total Common Shares Outstanding |